← FDA Drug Approvals (Drugs@FDA)
EZETIMIBE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2020-10-23
Drug application
- FDA Application #
ANDA210673- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EZETIMIBE
- Generic name
- EZETIMIBE
- Active ingredients
- EZETIMIBE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals Inc
- First approval
- 2020-10-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown